The rate of cognitive decline due to ageing is increased 1.5-fold to 2.0-fold in individuals with type 2 diabetes.There are no established specific treatment measures to prevent or ameliorate cognitive impairments in patients with diabetes. we want to detecte early clinical dementia in diabete.
Clinically relevant cognitive decrements in relation to diabetes mainly occur during two crucial periods in life: the period of brain development in childhood, and the period when the brain undergoes neurodegenerative changes associated with ageing.Potential leads for treatment are to optimise glycaemic control and avoid and treat vascular risk factors.we want to detecte early clinical dementia in diabete by MMSE and Olfactory function.
Study Type
OBSERVATIONAL
Enrollment
400
Wuhan general hospital of Guangzhou Command
Wuhan, Hubei, China
RECRUITINGtongji Medical University
Wuhan, Hubei, China
ENROLLING_BY_INVITATIONWuhan general hospital of Guangzhou command
Wuhan,chongqing, Hubei, China
ACTIVE_NOT_RECRUITINGMMSE Olfactory function dementia
MMSE,Olfactory function and PET(fMRI) were observed.
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.